Biomedicine Production of Essential Medicines
Biomedicine Production of Essential Medicines
Biomedicine Production of Essential Medicines
Plant Molecular Farming (PMF) produces vital therapies to mitigate drug shortages, strengthen domestic pharmaceutical production, and promote environmental sustainability. Engineered plants provide not just cutting-edge therapies, but vital economic opportunities that cultivate social impact.
Land Transformation of Industrial Sites
Biomedicine Production of Essential Medicines
Biomedicine Production of Essential Medicines
The fusion of cutting-edge AI, machine learning, synthetic biology and bio-manufacturing takes derelict and decommissioned sites and rehabilitates them into integrated production hubs.
The Bio-Digital Research Network
Medicines Manufactured from Revived Lands
Medicines Manufactured from Revived Lands
The Bio-DRN gamifies R&D across a collaborative ecosystem of top scientists, universities and visionary students fusing synthetic biology, AI, advanced manufacturing and environmental remediation. Student-led concepts translate into bio-economic startups transforming degraded lands into multi-generational bio-hubs.
Medicines Manufactured from Revived Lands
Medicines Manufactured from Revived Lands
Medicines Manufactured from Revived Lands
- Localizing production, globalizing impact, we empower underserved communities with equitable access to essential medicines and advanced sustainable manufacturing alike - a powerful synthesis of job creation, health equity and environmental sustainability.
Founders
Dr. Russell Hanson, CIO
Dr. Russell Hanson, CIO
Dr. Russell Hanson, CIO
Scientist, technologist, and entrepreneur with over 15 years of experience in artificial intelligence, health, data science, and cryptocurrencies. Co-founded and served as the Chief Scientific Officer of several companies in the AI and biotech domains, with successful exits and acquisitions. Conducted scientific and technical due dil
Scientist, technologist, and entrepreneur with over 15 years of experience in artificial intelligence, health, data science, and cryptocurrencies. Co-founded and served as the Chief Scientific Officer of several companies in the AI and biotech domains, with successful exits and acquisitions. Conducted scientific and technical due diligence on $100M+ transactions in AI drug discovery. Published scientific papers in peer-reviewed journals on AI and neurodegenerative disease, neuropathology, immunology, biosensors, and radiology. As a keynote speaker and conference moderator, Dr. Hanson have spoken at conferences worldwide on biotechnology, AI, cryptocurrencies, and neurotechnology for diverse audiences. My mission is to leverage AI, chemistry, synthetic biology, and data science to advance human health and wellbeing around the world.
James Walters, CEO
Dr. Russell Hanson, CIO
Dr. Russell Hanson, CIO
Oversees the biomedicine and bioremediation divisions at Avos BioGen. Roles include developing enterprise and agricultural partnerships and programs, effective outreach in underserved communities, and effective partnerships in media, entrepreneurship, as well as with farmers, local government, and outside organizations in education and eq
Oversees the biomedicine and bioremediation divisions at Avos BioGen. Roles include developing enterprise and agricultural partnerships and programs, effective outreach in underserved communities, and effective partnerships in media, entrepreneurship, as well as with farmers, local government, and outside organizations in education and equitable opportunities.
In 2022, Mr. Walters formed an elite team of researchers, educators, subject matter experts, and fuel operators to create a conglomerate effort united with a shared vision, to find and use the best, cutting edge science and technology to empower students and create sustainable technologies for emerging economies.